Bing

SEARCH HISTORY

Acura Pharmaceuticals, Inc. (NASDAQ: ACUR) 17.9% HIGHER; announced its next generation pseudoephedrine hydrochloride tablet, NEXAFED, is now being sold in over 2,600 pharmacies nationwide. Since its introduction in December 2012, NEXAFED …
StreetInsider · 9/19/2013
To date, Pfizer's partnership with Acura has been very lucrative ... this after calls to Publix pharmacies in 5 states confirming NEXAFED in stock), investors are likely to bid ACUR up in a manner seen when the less significant Kerr Drugs Store news ...
Seeking Alpha · 9/25/2013
at ACUR's average daily trading levels. Despite being down 3.6% this afternoon at $3.44, NEON has been in rally mode since touching a multi-year low of $1.72 in mid-October -- doubling over that time frame. Also, the stock is consolidating atop its ...
Schaeffer's Investment Research · 6/16/2015
PALATINE, IL--(Marketwired - July 01, 2015) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR) today announced it has entered into a Securities Purchase Agreement with certain institutional investors to sell 9,790,000 shares of common stock at a price of $0.
marketwired.com · 7/1/2015
On Tuesday, the stock was trading up around 52 percent in the final hour of trade to $3.11. Over the last year, ACUR has lost around 7 percent, although the shares have been very volatile. Year-to-date, the stock is now up around 41 percent. Acura ...
Benzinga · ByScott Rubin · 3/5/2013
WASHINGTON (dpa-AFX) - Acura Pharmaceuticals Inc. (ACUR) is down more than 22 percent to $1.44 in ... In pre-market trading Tuesday, the stock is up 1.45% to $10.50. Rigel Pharmaceuticals Inc. (RIGL) dropped 13.50 percent to $3.14 on Monday as …
Finanznachrichten · 8/27/2013
Acura Pharmaceuticals (ACUR): The small cap stock is begun with a Buy recommendation and $4 price objective at MLV & Co, which highlights its potential hydrocodone/acetaminophen products. AthenaHealth (ATHN): KeyBanc Capital Markets has a …
Minyanville · ByJustin Sharon · 8/14/2013
Your own personalized stock watchlist! It's a 100% FREE Motley Fool service ... An accurate assessment Also looking like it has a bright future is Acura Pharmaceuticals (NASDAQ: ACUR ) , the drug developer that makes compounds to discourage drug …
The Motley Fool · ByRich Duprey · 4/18/2013
The first trading day of March was a good day for the stock market and a lousy day for the Treasury market. The former rallied, featuring a return above 5,000 for the Nasdaq Composite and new record closes for both the Dow Jones Industrial Average and …
Briefing Live Market Analysis · 3/2/2015
Dec 09, 2013 (ACCESSWIRE via COMTEX) -- New York, December 09, 2013 /Accesswire/ - Market Buzz Report, a leading penny stock newsletters provider, issues major news alert for Gilead Sciences, Inc. GILD, +0.26% Acura Pharmaceuticals, Inc.
Market Watch · 12/9/2013